<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=yes">
  <title>CeFAZolin Dosage Information</title>

  <style>
    html, body {
      margin: 0;
      padding: 0;
    }

    body {
      font-family: Arial, sans-serif;
      background-color: #f9f9f9;
    }

    /* ‡∏Å‡∏•‡πà‡∏≠‡∏á‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡∏´‡∏≤‡πÉ‡∏´‡πâ‡∏≠‡∏¢‡∏π‡πà‡∏Å‡∏•‡∏≤‡∏á‡∏à‡∏≠ ‡πÅ‡∏•‡∏∞‡πÄ‡∏ß‡πâ‡∏ô‡∏î‡πâ‡∏≤‡∏ô‡∏•‡πà‡∏≤‡∏á‡πÄ‡∏ú‡∏∑‡πà‡∏≠‡∏õ‡∏∏‡πà‡∏°‡∏•‡∏≠‡∏¢ */
    .page-wrap {
      max-width: 900px;
      margin: 0 auto;
      padding: 24px 24px 150px;
      box-sizing: border-box;
      background-color: #fff;
      min-height: 100vh;
    }

    h1 {
      color: #fcf2f2;
      font-size: 28px;
      font-weight: bold;
      padding: 10px;
      border: 2px solid #afaaaa;
      border-radius: 10px;
      background-color: #2c8ed0;
      text-align: center;
    }

    .section-title {
      margin-top: 20px;
      font-size: 18px;
      font-weight: bold;
    }

    .highlight-dose {
      color: #ff5733;
      font-size: 24px;
      font-weight: bold;
      background-color: #fbe9e7;
      padding: 5px 10px;
      border-radius: 5px;
    }

    table {
      width: 100%;
      border-collapse: collapse;
      margin: 20px 0;
      font-size: 16px;
      text-align: center;
    }

    th, td {
      padding: 12px;
      border-bottom: 1px solid #ddd;
    }

    th {
      background-color: #f2f2f2;
    }

    .highlight {
      background-color: #c3e6cb;
    }

    ul {
      margin-left: 20px;
    }

    hr {
      border: none;
      border-top: 2px solid #ccc;
      margin: 20px 0;
      width: 100%;
    }

    footer.page-footer {
      text-align: center;
      color: #00000035;
      font-size: 13px;
      margin-top: 32px;
    }

    /* ===== ‡πÅ‡∏ñ‡∏ö‡∏õ‡∏∏‡πà‡∏°‡∏•‡∏≠‡∏¢‡∏î‡πâ‡∏≤‡∏ô‡∏•‡πà‡∏≤‡∏á ===== */
    .top-fix-actions {
      position: fixed;
      left: 50%;
      transform: translateX(-50%);
      bottom: max(8px, env(safe-area-inset-bottom, 0px));

      width: min(100% - 32px, 560px);
      box-sizing: border-box;

      display: flex;
      justify-content: center;
      gap: 12px;

      padding: 8px 12px;
      border-radius: 16px;
      background: rgba(0, 0, 0, 0.18);
      backdrop-filter: blur(6px);
      z-index: 1000;
    }

    .back-btn {
      display: inline-flex;
      align-items: center;
      justify-content: center;
      padding: 10px 20px;
      font-size: 16px;
      text-decoration: none;
      border-radius: 10px;
      border: none;
      box-shadow: 0 4px #999;
      color: #fff;
      background-color: #f44336;  /* Home = ‡πÅ‡∏î‡∏á */
      cursor: pointer;
      text-align: center;
      line-height: 1.2;
    }

    .back-btn.alt {
      background-color: #008CBA;   /* Back = ‡∏ü‡πâ‡∏≤ */
    }

    .back-btn:hover {
      filter: brightness(1.05);
    }

    .back-btn:active {
      transform: translateY(2px);
      box-shadow: 0 2px #666;
    }

    /* ===== ‡∏°‡∏∑‡∏≠‡∏ñ‡∏∑‡∏≠ ===== */
    @media (max-width: 600px) {
      .page-wrap {
        padding: 10px 10px 160px;
      }

      h1 {
        font-size: 20px;
        padding: 6px;
      }

      .section-title {
        font-size: 14px;
      }

      .highlight-dose {
        font-size: 20px;
      }

      table {
        font-size: 14px;
      }

      th, td {
        padding: 8px;
      }

      .top-fix-actions {
        width: min(100% - 20px, 420px);
        bottom: max(10px, env(safe-area-inset-bottom, 0px));
        gap: 8px;
      }

      .back-btn {
        font-size: 13px;
        padding: 8px 10px;
        flex: 1 1 0;
      }
    }
  </style>
</head>
<body>

  <div class="page-wrap">
    <h1>CeFAZolin Dosage Information</h1>

    <!-- PMA / PNA / BW -->
    <p><strong>PMA:</strong>
      
        0 weeks and 0 days
      
    </p>

    <p><strong>Calc.:</strong>
      
         weeks
      
    </p>

    <p><strong>Postnatal Age:</strong>
      
         days
      
    </p>

    <p><strong>Birth Weight (BW):</strong>
      
        0.00 kg
      
    </p>

    <!-- Calculated dose -->
    <div class="section-title">Calculated Dosage</div>
    <p>
      Recommended Dose:
      <span class="highlight-dose">
        
  - ‚Äì - mg/day

      </span>
    </p>
    <p>
      Interval:
      <span class="highlight-dose">
        
      </span>
    </p>

    <div class="section-title">Dose</div>
    <p>25 mg/kg/dose IV or IM.</p>

    <div class="section-title">Antibiotic Dosing Chart</div>
    <p>
      Renal function and drug elimination are most strongly correlated with Postmenstrual Age (PMA;
      equivalent to Gestational Age plus Postnatal Age). PMA is the primary determinant of dosing
      interval, with Postnatal Age as the secondary qualifier.
    </p>

    <table>
      <thead>
        <tr>
          <th colspan="3">Dosing Interval Chart</th>
        </tr>
        <tr>
          <th>PMA (weeks)</th>
          <th>Postnatal (days)</th>
          <th>Interval (hours)</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td rowspan="2">&lt;29</td>
          <td>0 to 28</td>
          <td>12</td>
        </tr>
        <tr>
          <td>&gt;28</td>
          <td>8</td>
        </tr>
        <tr>
          <td rowspan="2">30 to 36</td>
          <td>0 to 14</td>
          <td>12</td>
        </tr>
        <tr>
          <td>&gt;14</td>
          <td>8</td>
        </tr>
        <tr>
          <td rowspan="2">37 to 44</td>
          <td>0 to 7</td>
          <td>12</td>
        </tr>
        <tr>
          <td>&gt;7</td>
          <td>8</td>
        </tr>
        <tr>
          <td>&gt;45</td>
          <td>ALL</td>
          <td>6</td>
        </tr>
      </tbody>
    </table>

    <hr>

    <div class="section-title">Administration</div>
    <p>
      May be given by IV direct (bolus) injection, IV infusion, or IM injection.<br>
      For IV bolus injection, inject slowly over 3 to 5 minutes at a concentration of 100 mg/mL.<br>
      <strong>For IV infusion,</strong> dilute reconstituted solution to a concentration of
      <strong>5 to 20 mg/mL and infuse over 10 to 60 minutes.</strong><br>
      For IM injection, use a concentration of 225 mg/mL. Maximum 330 mg/mL.
    </p>

    <hr>

    <div class="section-title">Uses</div>
    <p>
      Use in neonates is generally limited to perioperative infection prophylaxis and treatment of urinary
      tract and soft tissue infections caused by susceptible organisms, e.g. penicillin-resistant
      <em>Staph. aureus</em>, <em>Klebsiella</em>, and <em>Proteus</em>.
    </p>

    <p>
      <strong>Infective endocarditis:</strong> The following recommendations are based on a consensus of experts [3].
      The full pediatric guidelines can be found here: https://doi.org/10.1161/CIR.0000000000000298
    </p>

    <table>
      <thead>
        <tr>
          <th colspan="3">Organism Directed Therapy</th>
        </tr>
        <tr>
          <th>Organism</th>
          <th>First-Choice</th>
          <th>Alternative Choice</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Streptococci</td>
          <td colspan="2"></td>
        </tr>
        <tr>
          <td>
            Highly susceptible to penicillin G (MBC 0.1 mcg/mL or less); includes most viridans
            streptococci, groups A, B, C, G nonenterococcal, group D streptococci
            (<em>S bovis, S equinus</em>)
          </td>
          <td>Penicillin G or CefTRIAXone</td>
          <td>Vancomycin or First-generation cephalosporin or CefTRIAXone</td>
        </tr>
        <tr>
          <td>
            Relatively resistant to penicillin (MBC 0.2 mcg/mL or more); less-susceptible viridans
            streptococci or enterococci
          </td>
          <td>
            Penicillin G or Ampicillin + Gentamicin
            (for first 2 weeks, or entire course for enterococci)
          </td>
          <td>
            Vancomycin + Gentamicin for enterococci or Ampicillin + CefTRIAXone
            (for AMG-resistant enterococci or AMG-intolerant patient) or CefTRIAXone + Gentamicin
            (not for enterococcal endocarditis)
          </td>
        </tr>
        <tr>
          <td>Resistant to penicillin</td>
          <td>Consult an infectious disease specialist.</td>
          <td>---</td>
        </tr>
        <tr>
          <td>Staphylococci (S aureus or coagulase-negative staphylococci) ‚Ä†</td>
          <td colspan="2"></td>
        </tr>
        <tr>
          <td>Penicillin G susceptible (1 mcg/mL or less) (rare)</td>
          <td>Penicillin G</td>
          <td>Oxacillin or Nafcillin or First-generation cephalosporin or Vancomycin</td>
        </tr>
        <tr>
          <td>Penicillin G resistant (0.1 mcg/mL)</td>
          <td>Oxacillin or Nafcillin with or without Gentamicin</td>
          <td>
            Vancomycin (for those highly allergic to beta-lactam antibiotics)
            or First-generation cephalosporin
          </td>
        </tr>
        <tr>
          <td>Oxacillin (MRSA) resistant (4 mcg/mL)</td>
          <td>Vancomycin</td>
          <td>Daptomycin for right-sided endocarditis, maybe for left-sided</td>
        </tr>
        <tr>
          <td>Vancomycin resistant or intolerant</td>
          <td>Daptomycin</td>
          <td>Unknown</td>
        </tr>
        <tr>
          <td></td>
          <td colspan="2">
            ‚Ä† When prosthetic material present add riFAMpin + gentamicin
            (for first 2 weeks) for all staphylococci
          </td>
        </tr>
        <tr>
          <td>Gram-negative enteric bacilli</td>
          <td>
            CefTAZidime or Cefepime or Cefotaxime or CefTRIAXone
            plus gentamicin (or tobramycin or amikacin, depending on susceptibility)
          </td>
          <td>
            Broad-spectrum penicillin plus gentamicin
            (or tobramycin or amikacin)
          </td>
        </tr>
        <tr>
          <td>HACEK group</td>
          <td>CefTRIAXone or Cefotaxime or Ampicillin-sulbactam</td>
          <td>Ampicillin (when susceptible) plus aminoglycoside</td>
        </tr>
        <tr>
          <td colspan="3" style="text-align: left;">
            <strong>KEY:</strong> AMG = aminoglycosides; HACEK = <em>Haemophilus</em> species,
            <em>Aggregatibacter</em> species, <em>Cardiobacterium hominis</em>,
            <em>Eikenella corrodens</em>, and <em>Kingella</em> species; MBC = minimum bactericidal
            concentration; MRSA = methicillin-resistant <em>Staphylococcus aureus</em>
            (includes resistance to oxacillin, nafcillin, and cephalosporins).
          </td>
        </tr>
      </tbody>
    </table>

    <footer class="page-footer">
      <p>Developed by Sukhontha Boonsookchan | update 2025-12-01 19:05</p>
    </footer>
  </div>

  <!-- ‡∏õ‡∏∏‡πà‡∏°‡∏•‡∏≠‡∏¢‡∏î‡πâ‡∏≤‡∏ô‡∏•‡πà‡∏≤‡∏á -->
  <div class="top-fix-actions" role="navigation" aria-label="Quick actions">
    <a href="javascript:history.back()" class="back-btn alt">‚¨Ö Back</a>
    <a href="./index.html" class="back-btn">üè† Back to Home</a>
  </div>

</body>
</html>